Citation: Gb. Faguet et Jf. Agee, THE CHRONIC LYMPHOCYTIC-LEUKEMIA ANTIGEN (CCLLA) AS IMMUNOTHERAPY TARGET - PHARMACOKINETICS AND BIODISTRIBUTION OF 2 DIVALENT, RICIN-BASED IMMUNOTOXINS IN XENOGRAFTED ATHYMIC MICE, Leukemia & lymphoma, 25(5-6), 1997, pp. 509-520
Citation: Gb. Faguet et Jf. Agee, THE CHRONIC LYMPHOCYTIC-LEUKEMIA ANTIGEN (CCLLA) AS IMMUNOTHERAPY TARGET - ASSESSMENT OF LD50 AND MTD OF 4 RICIN-BASED ANTI-CCLLA IMMUNOTOXINS (ITS) IN BALB C MICE/, Leukemia & lymphoma, 25(5-6), 1997, pp. 531-537
Citation: Gb. Faguet et Jf. Agee, THE CHRONIC LYMPHOCYTIC-LEUKEMIA ANTIGEN (CCLLA) FOR TARGETED IMMUNOTHERAPY - ASSESSMENT OF LD50 AND MTD OF 2 DIVALENT AND 2 MONOVALENT RICIN-BASED ANTI-CCLLA IMMUNOTOXINS (ITS) IN BALB C MICE/, Blood, 86(10), 1995, pp. 3314-3314
Citation: Gb. Faguet et al., USING THE CHRONIC LYMPHOCYTIC-LEUKEMIA ANTIGEN (CCLLA) FOR TARGETED IMMUNOTHERAPY - ASSESSMENT OF THE PHARMACOKINETICS AND BIODISTRIBUTION OF 2 DIVALENT, RICIN-BASED ANTI-CCLLA IMMUNOTOXINS (ITS) IN XENOGRAFTED NUDE-MICE, Blood, 86(10), 1995, pp. 3315-3315
Citation: Gb. Faguet et Jf. Agee, A SIMPLE TECHNIQUE FOR THE RAPID ENRICHMENT OF CLASS AND SUBCLASS HYBRIDOMA SWITCH VARIANTS - A 1000-FOLD ENRICHMENT IN HALF THE TIME, FOR HALF THE COST, Journal of immunological methods, 165(2), 1993, pp. 217-224